Clinical Trials Browser

Phase 2 × Squamous Cell Carcinoma of Head and Neck × Sunitinib × Clear all

NCT00408252 2019-09-19

Efficacy of SU 011248 in Head And Neck Carcinoma

Phase 2 Terminated

Squamous Cell Carcinoma of Head and Neck, Recurrence

NCT00387335 2014-07-25

Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Phase 2 Completed

22 enrolled 9 charts

Squamous Cell Carcinoma of Head and Neck